Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism, biomarkers and management
Background: Doxorubicin (DOX) is a widely used chemotherapeutic agent that is effective against various solid tumors and hematologic malignancies. However, its clinical application is severely limited by dose-dependent cardiotoxicity, which affects nearly 26% of patients. Objective: This review focu...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Creative Pharma Assent
2024-12-01
|
| Series: | Journal of Applied Pharmaceutical Research |
| Subjects: | |
| Online Access: | https://japtronline.com/index.php/joapr/article/view/673 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|